How to arrange the dosage and use time of Nilotinib

Nilotinib (Nilotinib) is an oral second-generation BCR-ABLtyrosine kinase inhibitor (TKI), mainly used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) patients, especially those who are intolerant or resistant to imatinib (Imatinib). In order to maximize the effectiveness of medications and reduce the risk of side effects, reasonable dosage and timing are crucial.

The recommended standard dose of nilotinib is usually 300 mg twice daily, approximately 12 hours apart. For acute phase or more complex patient conditions, the dose may be adjusted to 400 mg twice daily (twice daily), but this must be strictly under the guidance of a physician. This medicine is in capsule form and must be swallowed whole and cannot be broken, chewed or ground to ensure stable release of the medicine.

Nilotinib must be taken on an empty stomach, that is, no food is allowed for at least 2 hours before taking the drug and at least 1 hour after taking the drug. This is because food will significantly increase the plasma concentration of nilotinib, which may lead to an increased risk of adverse reactions, especially cardiac side effects such as QT interval prolongation. Therefore, patients should pay special attention to arranging their daily eating and medication time, try to take medication regularly, and avoid missing doses or too short intervals.

In addition, during treatment with nilotinib, patients should regularly monitor blood routine, liver function, electrolytes, electrocardiogram (especially the QT interval) to evaluate whether the dose needs to be adjusted or medication delayed based on the test results. If serious adverse reactions or abnormal laboratory indicators occur, the doctor should be informed in time, and the professional doctor will decide whether to reduce the dose, discontinue the drug, or take other intervention measures, so as to ensure the treatment effect while maximizing patient safety.

Reference materials:https://www.drugs.com/